• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Public Health

Fecal immunochemical testing may be efficient for colorectal cancer screening in younger patients

byJunghoon KoandThomas Su
November 4, 2024
in Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this retrospective cohort study, fecal immunochemical test completion rates in individuals aged 45 to 49 years were slightly higher than those aged 50 years, and positivity rates were slightly lower in the younger cohort.

2. Receipt of colonoscopy after a positive fecal immunochemical test was similar in both age groups, but the false-positive rate was higher among the younger group.

Evidence Rating Level: 2 (Good)

Study Rundown: Colorectal cancer (CRC) is associated with significant morbidity and mortality worldwide. CRC screening involves the detection of pre-cancerous lesions and early-stage cancer in asymptomatic individuals. Previous guidelines recommended starting CRC screening at 50 years of age for average-risk individuals, but several organizations including the American Cancer Society, the United States Preventive Services Task Force, and the American College of Gastroenterology have advised starting screening at 45 years of age based on increasing disease burden in younger populations. However, there is little data available on screening completion rates and outcomes in this younger population. This retrospective cohort study aimed to investigate rates of fecal immunochemical testing (FIT) completion, FIT positivity, and colonoscopy follow-up after a positive FIT, as well as colonoscopy yield in individuals aged 45 to 49 years versus 50 years across 3 Kaiser Permanente health systems. It was found that FIT completion rates were slightly higher overall in individuals aged 45 to 49 years, although there was substantial variation across sites. FIT positivity was slightly lower in the younger cohort, but receipt of colonoscopy following a positive FIT was similar in both age groups. On colonoscopy, colorectal cancer was detected at a similar rate between the two groups, but detection of any adenoma was slightly lower among those aged under 50 years. Given that the study only sampled patients within select Kaiser Permanente systems, its generalizability to other health care settings is limited. In addition, the low rates of neoplasia events rendered wide confidence intervals on specific risk ratio estimates. Overall, these results suggested that colorectal cancer screening yield in adults aged 45 to 49 years was similar to that of those aged 50 years and above.

Click to read the study in AIM

Relevant Reading: Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on colorectal cancer

RELATED REPORTS

A lower volume of polyethylene glycol with ascorbate (MoviPrep) may improve bowel cleansing prior to colonoscopy

Increasing cancer incidence rates in younger and older adults worldwide

Personalized risk messages may not increase colorectal cancer screening uptake

In-Depth [retrospective cohort]: This retrospective cohort study aimed to compare the completion rates and yield of FIT between persons aged 45 to 49 years and 50 years. Individuals were eligible if they were registered within Kaiser Permanente health systems and had a documented FIT kit distribution date between January and September 2022. Patients with a prior colonoscopy, prior lower gastrointestinal surgery, history of CRC, or inflammatory bowel disease were excluded. The primary study outcomes included FIT completion within 3 months of the FIT distribution date, the proportion of FITs with a positive result, follow-up colonoscopy completion within 3 months of a positive FIT result, and colonoscopy findings. A total of 213,928 individuals aged 45 to 49 years and 53,804 individuals aged 50 years were included in the study. Overall, FIT completion rates were slightly higher in the younger cohort (38.9% vs. 37.5%; adjusted risk ratio [aRR], 1.05; 95% confidence interval [CI], 1.04 to 1.06). FIT positivity was lower in the younger group (3.6% vs. 4.0%; aRR, 0.91; 95% CI, 0.84 to 0.98) and colonoscopy completion following a positive FIT result was similar between both groups (64.9% vs. 67.4%; aRR, 1.00; 95% CI, 0.94 to 1.05). Detection rates were lower in the younger group for adenomas (58.8% vs. 67.7%; aRR, 0.88; 95% CI, 0.83 to 0.95) but similar between groups for polyps with high-grade dysplasia (3.4% vs. 5.1%; aRR, 0.68; 95% CI, 0.44 to 1.04), sessile serrated lesions (10.3% vs.11.7%; aRR, 0.92; 95% CI, 0.71 to 1.21), and CRC (2.8% vs.2.7%; aRR, 1.10; 95% CI, 0.62 to 1.96). In summary, this study demonstrates similar FIT completion and yield rates between individuals 45 to 49 and 50 years of age.

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: colorectal cancer (CRC)colorectal cancer screeningpositive fecal immunochemical test (FIT)screening guidelines
Previous Post

2 Minute Medicine Rewind November 4, 2024

Next Post

#VisualAbstract: Atrasentan Reduced Proteinuria in IgA Nephropathy

RelatedReports

Endoscopic screening for esophageal cancer may reduce long-term mortality
Gastroenterology

A lower volume of polyethylene glycol with ascorbate (MoviPrep) may improve bowel cleansing prior to colonoscopy

May 26, 2026
Population-based risk factors and geographical trends identified for vitiligo
Oncology

Increasing cancer incidence rates in younger and older adults worldwide

October 20, 2025
2 Minute Medicine Rewind October 21, 2019
Gastroenterology

Personalized risk messages may not increase colorectal cancer screening uptake

September 1, 2025
Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening
Gastroenterology

Birth cohort effects observed for increased appendiceal adenocarcinoma incidence

August 27, 2025
Next Post
#VisualAbstract: Atrasentan Reduced Proteinuria in IgA Nephropathy

#VisualAbstract: Atrasentan Reduced Proteinuria in IgA Nephropathy

#VisualAbstract: Methadone is a Better Treatment for Opioid Use Disorder than Buprenorphine/Naloxone

#VisualAbstract: Methadone is a Better Treatment for Opioid Use Disorder than Buprenorphine/Naloxone

Significant reduction in prostate screening rates after revised guidelines

Novel colorectal cancer screening tests’ utility depends on patient context

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis
  • Why Pfizer Is Looking East for Its Next Generation of Cancer Drugs
  • 2MM: Pharma Roundup – Pfizer’s $10.5B Innovent oncology partnership, Guselkumab (Tremfya) gains a broader psoriatic arthritis label, Venetoclax (Venclyxto) expands first-line CLL options, and Seladelpar (Livdelzi) advances in primary biliary cholangitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.